Cardinal Health has reported strong first quarter financial results, causing its stock to surge. The company's performance may be part of a larger trend, with other companies such as Medtronic also posting strong quarters. However, the implications of these developments for investors and the pharmaceutical industry as a whole are unclear, with some outlets suggesting potential buying opportunities and others highlighting unexpected earnings results.